Page last updated: 2024-09-05

sorafenib and Encephalopathy, Hypertensive

sorafenib has been researched along with Encephalopathy, Hypertensive in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adusumilli, J; Baxter, DL; El-Khoueiry, A; Govindarajan, R; Harik, SI	1

Other Studies

1 other study(ies) available for sorafenib and Encephalopathy, Hypertensive

Article	Year
Reversible posterior leukoencephalopathy syndrome induced by RAF kinase inhibitor BAY 43-9006. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Oct-01, Volume: 24, Issue:28 Topics: Angiogenesis Inhibitors; Benzenesulfonates; Cholangiocarcinoma; Clinical Trials as Topic; Enzyme Inhibitors; Female; Humans; Hypertensive Encephalopathy; Magnetic Resonance Imaging; Middle Aged; Niacinamide; Phenylurea Compounds; Pyridines; raf Kinases; Sorafenib; Syndrome	2006

Article

Year

Reversible posterior leukoencephalopathy syndrome induced by RAF kinase inhibitor BAY 43-9006.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Oct-01, Volume: 24, Issue:28

Topics: Angiogenesis Inhibitors; Benzenesulfonates; Cholangiocarcinoma; Clinical Trials as Topic; Enzyme Inhibitors; Female; Humans; Hypertensive Encephalopathy; Magnetic Resonance Imaging; Middle Aged; Niacinamide; Phenylurea Compounds; Pyridines; raf Kinases; Sorafenib; Syndrome

2006